The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
SAN FRANCISCO – New studies on the treatment of genitourinary cancers were released today in advance of the third annual Genitourinary Cancers Symposium, being held March 5-7, 2010, at the San Francisco Marriott.
ALEXANDRIA, VA. — The challenges facing young women with breast cancer, and the promise of high-tech cancer care in rural settings, are the subjects of innovative new grants addressing real-life issues in cancer care, awarded by the ASCO Cancer Foundation®, with funding from Susan G. Komen for the Cure®.
ALEXANDRIA, Va. — The ASCO Cancer Foundation will present Merit Awards to twenty-five leading oncology fellows from around the world at the 2010 Genitourinary (GU) Cancers Symposium, which takes place March 5-7 in San Francisco. These promising young fellows will be honored for their exceptional contributions to the research of genitourinary tract cancers.
ALEXANDRIA, Va. – Four studies from the third annual Genitourinary Cancers Symposium Press Program will be highlighted in an embargoed presscast (press briefing via phone and webcast) on Wednesday, March 3, from 12:00-1:00 PM (EST).
ALEXANDRIA, Va. - In this News Digest you will read a summary of a study being published online February 16, 2010, in the Journal of Clinical Oncology, finding that breast cancer patients who took aspirin had a nearly 50 percent reduced risk of metastasis and death from the disease.
ALEXANDRIA, Va. —The American Society of Clinical Oncology (ASCO) and Harborside Press announced today a commitment to launch a new monthly publication for the cancer community, The ASCO Post. This newspaper-style publication will report on the latest news in clinical cancer research, patient care and policy, and include timely commentary on the most important issues facing the field. Harborside Press, formerly Cold Spring Publishing, is an independent medical publishing company whose leadership and management team has more than 50 years of experience in oncology.
In this News Digest, you will find a summary of a study published online January 25, 2010, in the Journal of Clinical Oncology, showing that progression-free survival in patients with advanced renal cell carcinoma who received pazopanib (VOTRIENT) was more than twice as long as in those who received a placebo.
ORLANDO, Fla. – Seven additional studies on the early detection, treatment and prevention of gastrointestinal cancers were highlighted today by the co-sponsoring organizations of the 2010 GI Cancers Symposium. The symposium is being held January 22-24 at the Orlando World Center Marriott in Florida.
ORLANDO, Fla.– New research on the treatment of gastrointestinal cancers was released today in advance of the seventh annual Gastrointestinal Cancers Symposium, being held January 22-24, 2010, at the Orlando World Center Marriott.
ALEXANDRIA, Va. — The ASCO Cancer Foundation will present Merit Awards to twenty-five leading oncology fellows from around the world at the 2010 Gastrointestinal (GI) Cancers Symposium, which takes place January 22-24 in Orlando. These bright, young minds will be honored for their exceptional contributions to the research of gastrointestinal tract cancers.
